URSAPHARM becomes partner of FIS Ski Jumping World Cup

Saarbrücken, 24 November 2023.  FIS is pleased to announce that URSAPHARM Arzneimittel GmbH and its premium brand HYLO® will join the FIS Ski Jumping World Cup family as its presenting partner through the 2023-2025 seasons.

The HYLO® product family is Germany’s market leader for eye drops and ointments to alleviate the symptoms of dry eyes. During the winter season, cold temperatures, draughts as well as warm, dry air indoors can be very demanding for our eyes. The partnership with HYLO® therefore is a very good match.

“URSAPHARM operates under the motto ‘Innovation is our vision’ and for FIS that says everything that this partnership will be built on,” said FIS Chief Commercial Director Christian Salomon. “Time and time again, Ski Jumping has proven itself to captivate audiences around the world as an individual and team sport combining skill, technique, and bravery. As one of the most traditional winter sports it thrives constantly for innovation such as better equipment, new records and locations, keeping it exciting for all generations of sports fans to enjoy.”

“Dry, irritated or watery eyes are something that many winter sports fans are certainly familiar with. With our HYLO® product family, we provide an effective and safe solution to relief such symptoms and protect the eyes,” said Christian Krensel, Global Director Marketing & Sales at URSAPHARM. “This long-term partnership with FIS is a very good way to reach a broad and international audience with this important message.”

The FIS Ski Jumping World Cup was established in 1979, with the women their debut on the World Cup stage in 2011. The World Cup features a variety of events including the individual normal hill, individual large hill and mixed team events. Ski Jumping is the most geographically diverse of all of the FIS disciplines with regular competitions across central Europe, Scandinavia, Asia and North America.

The Ski Jumping season spans from November through the end of March and features approximately 40 competitions each season. Additionally, the sport features a summer series, known as the Summer Grand Prix, allowing athletes to train on the hills without snow during the late summer months. The current World Record jumping distance is held by Austrian Stefan Kraft, who went 253.5 metres on the Ski Flying hill in Vikersund (NOR).

Being a partner with German record football champion FC Bayern Munich since 2017, URSAPHARM has been no stranger to international sports engagements in the past. The company’s activities are rounded off by further football sponsorships as well as other engagements in areas such as tennis, badminton and motorsport.


About FIS
FIS is the governing body for international skiing and snowboarding, founded in 1924 during the first Olympic Games in Chamonix, France. Recognized by the International Olympic Committee (IOC), FIS manages the Olympic disciplines of Alpine Skiing, Cross-Country Skiing, Ski Jumping, Nordic Combined, Freestyle Skiing, Snowboarding and Para Snowsports, including setting the international competition rules. Through its 140 member nations, more than 7’500 FIS ski and snowboard competitions are staged annually. Specific initiatives are undertaken by FIS to promote snow activities as a healthy leisure recreation, notably for the young.

About URSAPHARM – made in Germany
URSAPHARM Arzneimittel GmbH is an internationally operating medium-sized pharmaceutical company that has established itself as the market leader in Germany and one of the leading suppliers in Europe thanks to its broad and high-quality product range in the field of ophthalmology. Since its foundation in 1974, URSAPHARM has been a guarantor for the consistent transfer of innovative pharmaceutical concepts into successful medicinal products and medical devices – one of the most successful developments is the HYLO® product family of eye drops and ointments for lubricating the eyes. The product portfolio is rounded off by various preparations for general medicine in the form of film-coated tablets, capsules, granules, sprays and ointments. In addition, URSAPHARM provides its expertise in development, production, quality control and quality assurance as a high-performance contract manufacturer and co-operation partner worldwide. Headquartered in Saarbrücken, the company has subsidiaries in France, Benelux, Italy, Austria, Switzerland, Poland, the Czech Republic, Slovakia, Portugal, Serbia, Russia and India as well as co-operation agreements with distribution partners in over 80 countries.



We use a cookie-less web analysis tool (etracker). For more information and to opt-out, please click here.